Aim
It is our goal to open up new pathways to a more just medication evaluation. Disadvantages of for example practices with a broad treatment range should be prevented through reasonable management. Simultaneously, an improvement of the treatment quality is worth aiming at. What does that mean for the patients? They receive the necessary and adequate therapy they deserve and that the doctor can prescribe to the best of his knowledge and conscience.
Partners
Within the WirtMed study, the Institute of General Practice of the UK Erlangen will cooperate with the consortium leader Department for General Practice of the Philipps University Marburg (project manager is Prof. Dr. med. N. Donner-Banzhoff) for the two sub-studies in a consortia project funded by the Innovation Fund of the Joint Federal Committee.